After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Pacific Biosciences of California Inc. (PACB) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.01, or -0.09%, to $11.06. The Pacific Biosciences of California Inc. has recorded 73,708 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Stocks Info
As a NASDAQ listed company, PACB falls under the Healthcare sector while operating within the Diagnostics & Research industry segment. At the end of the last regular session, the stock closed at $11.07 and fluctuated between $11.55 as its day high and $10.67 as its day low. The current market capitalization of Pacific Biosciences of California Inc. is $2.74B. A total of 5.63 million shares were traded on the day, compared to an average of 4.66M shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, PACB has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 71,722 shares. Over the last 12 months, there were 8 BUYs and 9 SELLs from insiders. Insiders purchased 927,500 shares during that period but sold 5,034,431.
In the most recent transaction, Van Oene Mark sold 26,722 shares of PACB for 9.53 per share on Jan 10. After the transaction, the insider now owns 640,808 company shares. In a previous transaction on Dec 01, HENRY CHRISTIAN O sold 45,000 shares at 10.84 per share. PACB shares that insider owns now total 643,551.
Among the insiders who sold shares, Kim Susan G. disposed of 12,968 shares on Sep 29 at a per-share price of $5.61. This resulted in the insider holding 163,488 shares of PACB after the transaction. In another insider transaction, HENRY CHRISTIAN O sold 91,307 shares at $5.78 per share on Sep 15. Company shares held by the insider now total 688,551.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for PACB in the last 3 months, the mean price target is $12.14 with high estimates of $14.00 and low estimates of $10.00. In terms of 52-week highs and lows, PACB has a high of $14.20 and a low of $3.85.
As of this writing, PACB has an earnings estimate of -$0.33 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.36. The company reported an EPS of -$0.37 in the last quarter, which was -19.40% lower than expectations of -$0.31.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 7 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PACB is Overweight with a score of 3.86. A total of 3 analysts rated the stock as Buy while 0 rated it as Overweight while 4 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.
